CI

At a glance

ClinicalIndex Comparison Record
Early Ph 1Completed· 12 enrolled
Drug / intervention
Oxytocin +1 moredrug
Likely dose
Oxytocin 20 IUfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01780337
NCT01780337Early Ph 1Completed
CompareCT.gov

Pilot Study of Intranasal Oxytocin and Cardiac Electrophysiology in Humans

William Whang·interventional·Posted Jan 31, 2013·Updated Jul 21, 2016

In Brief

A Early Phase 1 clinical trial evaluating Oxytocin and Saline for Cardiac Arrhythmia. Completed, enrolled 12 participants across 1 site.

Detailed Summary

In this pilot study the investigators will perform a double-blind randomized trial of intranasal oxytocin on measures of cardiac refractoriness, among individuals who are undergoing clinically indicated catheter ablation procedures for paroxysmal atrial fibrillation. The investigators seek to enroll 20 patients for this study, for the purpose of estimating effect sizes for a larger future study.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCardiac Arrhythmia
CountriesUnited States
Collaborators--

Timeline

Early Ph 1CompletedFinished
20132014201520162017201820192020202120222023202420252026
First PostedJan 31, 2013
Enrollment StartJan 1, 2013
Primary CompletionMay 1, 2016
TodayJul 2, 2026
Enrollment to primary: 3.3 yearsPosted 13.4 years ago

Interventions

Oxytocindrug

Intranasal dose of 20 IU oxytocin

Salineother

Intranasal dose of saline